111 related articles for article (PubMed ID: 23172532)
1. [Predicting value of dynamic alteration of blood neutrophil/lymphocyte ratio on recurrence-free survival in patients with advanced colon cancer after operation and chemotherapy].
Li J; Jia YB; Cai CN; Guan XD; Li PP; Xie YY; Zhang BM
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Nov; 15(11):1171-4. PubMed ID: 23172532
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
[TBL] [Abstract][Full Text] [Related]
3. [An elevated neutrophil/lymphocyte ratio is associated with poor prognosis in stage II resected colon cancer].
Urrejola GI; Bambs CE; Espinoza MA; Gellona J; Zúñiga AM; Molina ME; Bellolio F; Miguieles R; Campbell JM; Pinedo GA
Rev Med Chil; 2013 May; 141(5):602-8. PubMed ID: 24089275
[TBL] [Abstract][Full Text] [Related]
4. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer.
Ding PR; An X; Zhang RX; Fang YJ; Li LR; Chen G; Wu XJ; Lu ZH; Lin JZ; Kong LH; Wan DS; Pan ZZ
Int J Colorectal Dis; 2010 Dec; 25(12):1427-33. PubMed ID: 20821217
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Lymphocyte Counts in Colon Cancer Patients Treated with FOLFOX Chemotherapy.
Noh OK; Oh SY; Kim YB; Suh KW
World J Surg; 2017 Nov; 41(11):2898-2905. PubMed ID: 28707088
[TBL] [Abstract][Full Text] [Related]
6. Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.
Absenger G; Szkandera J; Stotz M; Postlmayr U; Pichler M; Ress AL; Schaberl-Moser R; Loibner H; Samonigg H; Gerger A
Anticancer Res; 2013 Oct; 33(10):4591-4. PubMed ID: 24123035
[TBL] [Abstract][Full Text] [Related]
7. Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy.
Zaanan A; Fléjou JF; Emile JF; Des GG; Cuilliere-Dartigues P; Malka D; Lecaille C; Validire P; Louvet C; Rougier P; de Gramont A; Bonnetain F; Praz F; Taïeb J
Clin Cancer Res; 2011 Dec; 17(23):7470-8. PubMed ID: 21998335
[TBL] [Abstract][Full Text] [Related]
8. Blood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4.
el Aziz LM
Med Oncol; 2014 Dec; 31(12):311. PubMed ID: 25367855
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival.
Peng W; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
J Surg Res; 2014 Dec; 192(2):402-8. PubMed ID: 24998425
[TBL] [Abstract][Full Text] [Related]
11. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in advanced colorectal cancer patients receiving oxaliplatin-based chemotherapy.
Kaneko M; Nozawa H; Sasaki K; Hongo K; Hiyoshi M; Tada N; Murono K; Nirei T; Kawai K; Sunami E; Tsuno NH; Kitayama J
Oncology; 2012; 82(5):261-8. PubMed ID: 22538399
[TBL] [Abstract][Full Text] [Related]
12. Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome.
Murray NP; Villalon R; Hartmann D; Rodriguez PM; Aedo S
Asian Pac J Cancer Prev; 2022 Feb; 23(2):591-599. PubMed ID: 35225472
[TBL] [Abstract][Full Text] [Related]
13. Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer.
Wang Y; Liu P; Xu Y; Zhang W; Tong L; Guo Z; Ni H
Cancer Chemother Pharmacol; 2015 Feb; 75(2):255-62. PubMed ID: 25428515
[TBL] [Abstract][Full Text] [Related]
14. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction.
Yuan D; Zhu K; Li K; Yan R; Jia Y; Dang C
J Surg Oncol; 2014 Sep; 110(3):333-40. PubMed ID: 24889121
[TBL] [Abstract][Full Text] [Related]
15. High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer.
Rossi L; Santoni M; Crabb SJ; Scarpi E; Burattini L; Chau C; Bianchi E; Savini A; Burgio SL; Conti A; Conteduca V; Cascinu S; De Giorgi U
Ann Surg Oncol; 2015 Apr; 22(4):1377-84. PubMed ID: 25234022
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: A propensity score-matched analysis.
Galizia G; Lieto E; Zamboli A; De Vita F; Castellano P; Romano C; Auricchio A; Cardella F; De Stefano L; Orditura M
Surgery; 2015 Jul; 158(1):112-20. PubMed ID: 25818659
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer.
Chae S; Kang KM; Kim HJ; Kang E; Park SY; Kim JH; Kim SH; Kim SW; Kim EK
Curr Oncol; 2018 Apr; 25(2):e113-e119. PubMed ID: 29719435
[TBL] [Abstract][Full Text] [Related]
18. [Assessment value of preoperative neutrophil-lymphocyte ratio for the prognosis of patients with colorectal cancer after radical operation].
Liu HL; Du XH; Sun PM; Xiao CH; Zou ZY; Xu YX
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Aug; 16(8):723-6. PubMed ID: 23980040
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of tumor-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in patients with stage III colon cancer who underwent surgery followed by FOLFOX chemotherapy.
Cha YJ; Park EJ; Baik SH; Lee KY; Kang J
Sci Rep; 2019 Aug; 9(1):11617. PubMed ID: 31406179
[TBL] [Abstract][Full Text] [Related]
20. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
